Dat Ngo Selected Research

Dat Ngo Research Topics

7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 10/2020
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 10/2013
4	Neoplasms (Cancer) 01/2024 - 10/2013
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 11/2021
2	Hemorrhagic Cystitis 01/2022 - 10/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2024
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	COVID-19 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023
1	Disease Progression 01/2023
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2023
1	Macrophage Activation Syndrome 01/2023
1	Cardiotoxicity 01/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2022
1	Residual Neoplasm 02/2022
1	Severe Acute Respiratory Syndrome 11/2021
1	Water Intoxication 10/2021
1	Hyperbilirubinemia 12/2020
1	Central Nervous System Diseases (CNS Diseases) 12/2019
1	Venous Thromboembolism 01/2019
1	Tumor Lysis Syndrome 08/2015
1	Postoperative Nausea and Vomiting (PONV) 03/2015
1	Leukemia 10/2013
1	Mucositis 10/2013
1	Sepsis (Septicemia) 10/2013
1	Neutropenia 10/2013
1	Infections 10/2013

4	venetoclaxIBA 01/2024 - 10/2020
3	blinatumomabIBA 11/2022 - 12/2019
2	fms-Like Tyrosine Kinase 3IBA 01/2024 - 10/2020
2	AnthracyclinesIBA 01/2023 - 01/2023
2	Inotuzumab OzogamicinIBA 01/2023 - 12/2022
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 01/2021
2	VaccinesIBA 01/2023 - 11/2021
2	Monoclonal AntibodiesIBA 01/2023 - 01/2023
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2021
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2021 - 10/2013
1	midostaurinIBA 04/2024
1	gilteritinibIBA 01/2024
1	fludarabineIBA 01/2023
1	purineIBA 01/2023
1	Etoposide (VP 16)FDA LinkGeneric 01/2023
1	InterferonsIBA 01/2023
1	Cladribine FDA LinkGeneric 01/2023
1	Sirolimus (Rapamycin)FDA Link 01/2023
1	Topoisomerase InhibitorsIBA 01/2023
1	Calcineurin InhibitorsIBA 01/2022
1	Mesna (Coenzyme M)FDA LinkGeneric 10/2021
1	Biosimilar PharmaceuticalsIBA 01/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 12/2020
1	Transaminases (Aminotransferases)IBA 12/2020
1	AntithrombinsIBA 01/2019
1	pegaspargase (Oncaspar)FDA Link 01/2019
1	GlucocorticoidsIBA 03/2015
1	fosaprepitant FDA Link 03/2015
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 03/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2013

5	Drug Therapy (Chemotherapy) 04/2024 - 12/2019
3	Therapeutics 01/2023 - 02/2022
2	Transplantation 01/2023 - 01/2022
1	Central Venous Catheters 01/2024
1	Art Therapy 01/2023
1	Cell Transplantation 01/2023
1	Renal Dialysis (Hemodialysis) 12/2022
1	Homologous Transplantation 10/2021
1	Continuous Renal Replacement Therapy 08/2015
1	General Anesthesia 03/2015
1	Premedication 03/2015